Journal
CHEMICAL & PHARMACEUTICAL BULLETIN
Volume 62, Issue 4, Pages 386-391Publisher
PHARMACEUTICAL SOC JAPAN
DOI: 10.1248/cpb.c13-00796
Keywords
carborane; estrogen receptor; subtype selectivity; estrogenic activity; docking study
Funding
- Ministry of Education, Culture, Sports, Science and Technology of Japan [20390035, 21790116]
- Grants-in-Aid for Scientific Research [24790115, 20390035, 21790116] Funding Source: KAKEN
Ask authors/readers for more resources
The two subtypes of estrogen receptor (ER), ER alpha and ER beta, differ greatly in expression pattern and biological functions, and ER beta-selective ligands candidates to treat immune-related disorders. ER beta-selective ligands have mostly been designed based the idea of introducing a substituent that interferes sterically with the ligand's interaction with Met421 to selectively decrease the affinity for ER alpha (the equivalent residue in ER beta is Ile373). Therefore, we designed and synthesized a series of carboranyl phenol derivatives bearing an aliphatic substituent as candidate ER beta-selective ligands. Introduction of a longer aliphatic substituent into the carboranyl moiety enhanced the ER beta selectivity of o-carboranyl phenol derivatives 4, but not m-carboranyl bisphenol derivatives 5. Compound 4c showed 7.4-fold ER beta selectivity in ER-binding assay and exhibited moderate estrogenic activity in cell proliferation assay using MCF-7 cell line.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available